ABSTRACT The sialic-rich carbohydrate moiety of the neural cell adhesion molecule (N-CAM) undergoes major structural changes during development and plays a significant role in altering the homophilic binding of the molecule. In order to understand the mechanism of these changes, a cyanogen bromide (CNBr) fragment that contained 90% of the sialic acid of N-CAM was isolated and characterized according to the number of carbohydrate attachment sites and reactivity with specific monoclonal antibodies. The CNBr sialopeptide migrated on SDS PAGE as a broad zone of Mr 42,000-60,000. Upon treatment with neuraminidase, it was converted to a single component of Mr 42,000, and subsequent, limited treatment with endoglycosidase F gave four evenly spaced components of Mr 35,000-42,000, suggesting that it contained three attachment sites for N-linked oligosaccharides. The fragment reacted with monoclonal antibody 15G8, which detects the sialic acid in embryonic N-CAM, and with a monoclonal antibody, anti-(N-CAM) No. 2. Treatment with neuraminidase or with endoglycosidase F destroyed reactivity with 15G8 but not with anti-(N-CAM) No. 2. A similar CNBr sialopeptide was obtained from adult N-CAM; it contained sialic acid, had three N-linked oligosaccharides and reacted with anti-(N-CAM) No. 2 but not with 15G8 monoclonal antibodies. A peptide fragment, Fr2, comprising the NH2 terminal and middle regions of the molecule yielded a CNBr fragment closely similar to the fragment obtained from the whole molecule. The CNBr fragment from Fr2 reacted with monoclonal antibody anti-(N-CAM) No. 2. Frl, comprising the NH2 terminal region alone, failed to react. These data confirm that the majority of the sialic acid is localized in the middle region of the N-CAM molecule and support the hypothesis that embryonic to adult conversion of N-CAM is the result of differences in sialidase or sialytransferase activity.
In view of the functional significance of these modulatory events, and to understand the mechanism of modulation, it is particularly important to confirm that E-A conversion involves only the loss of sialic acid and not of sugar attachment sites. To resolve this issue, we have isolated a cyanogen bromide (CNBr) fragment from embryonic and adult N-CAM that accounts for the bulk of the central region of the molecule represented by the difference between Frl and Fr2 (Fig. 1) . The adult sialopeptide was found to have less sialic acid than the embryonic peptide, but both had three N-linked oligosaccharides. This suggests that conversion does not occur by the removal or absence of the sites themselves, and favors the hypothesis that E-A conversion occurs either by the removal of sialic acid from the E form, or its failure to be attached to one or more of these sites.
CROSSIN ET AL.
MATERIALS AND METHODS
N-CAM was prepared as described (6, 8) . Reduced and alkylated (13) protein was treated with CNBr by adding 8-10 mg N-CAM to 2 ml of water; 90% formic acid was then added to a final concentration of 70%. Under these conditions, the protein was soluble after sonication. Solid CNBr (450 mg) was added to the protein solution. After 45 rain at room temperature, 100 ml of water was added and the reaction mixture was lyophylized repeatedly from water until the odor of formic acid was no longer detectable. This material was dissolved in 0.1 M NILHCO3, and centrifuged at 15,000 g for i 0 rain, and the supernatant was loaded onto a column of Sephacryl S-300 (1.6 x 100 cm) in 0.1 M NI-UHCO3.
Specific anti-N-CAM polyctonal and monoclonal antibodies were prepared and screened as described (3, 4, 6, 14) . N-CAM and N-CAM CNBr fragments were separated by SDS PAGE and stained with "Stains-all" (Eastman Kodak Co., Rochester, NY) (15), Coomassie Blue, or silver (16); alternatively, they were electrophoretically transferred to nitrocellulose paper, and reacted with rabbit polyclonal or mouse monoclonal antibodies followed by 1251-protein A as described (17) . For peptide mapping, N-CAM and fragments from gels were treated with Staphylococcus aureus V-8 protease (0.25 ug/iane) and the products were resolved by SDS PAGE (17) (18) (19) . Gels were calibrated with the following molecular weight standards purchased from Sigma Chemical Co. Digestion of N-CAM and N-CAM CNBr fragments (~ 1 mg]ml) with neuramiuidase (1 U/ml) from Vibrio cholera (Calbiochem-Behring Corp., San Diego, CA) was carried out in 0.1 M sodium acetate, 0.2 mM EDTA, 2 mM Caa2 for 18 h at 37"C. Alternatively, for peptide mapping experiments, N-CAM was treated with neuraminidase on an immunoaffinity support as described (11). Digestion of N-CAM and N-CAM CNBr fragments with endo-/~-N-acetylglucosaminidase F (Endo F) was done according to the method of Elder and Alexander (20) . The substrate (5-20/~g) was dissolved in 10 #l 2.2 mM Tris-HCl, pH 7.4, 11% Trasylol, 2.2% SDS, and 0.11 M dithiothreitol, and boiled for 3 min. The solution was cooled and 5 #l of 9% Nonidet P-40, 4 mg/ml phenylmethylsulfonyl fluoride solution was added. To this mixture 30 #l of enzyme solution was added. The enzyme solution contained 100 U/ml Eodo F, 0.17 M sodium phosphate buffer, pH 6.1, and 83 mM EDTA. The mixtures were incubated at 37"(2 for 20 h. There are several indications that proteolysis does not influence the results of glycosidase digestions. The changes in molecular weight agree with those expected for removal of sugar moieties. The products of endoglycosidase F or neuraminidase treatment of the CNBr sialopepfide are the same for incubation times ranging from 16 to 48 h. As noted above, protease inhibitors are included in the endoglycosidase F incubation mixture. Storage of the CNBr siaiopeptide under a variety of conditions indicate that it is a very stable peptide. Moreover, endoglycosidase F treatment of the liver cell adhesion molecule (21) , which is extremely sensitive to proteolysis yielding a distinctive fragment, shows no evidence for proteolysis. Control incubations were performed in parallel and treated as above substituting water for the enzyme. Enzyme preparations were tested using ovalbumin as a control substrate.
Sialic acid determinations were performed by reaction with thiobarbituric acid (22) after acid hydrolysis in 0.1 N H2SO4 for 4 h. Amino acid analyses were performed on a Beckman 121 M amino acid analyzer (Beckman Instruments, Inc., Fullerton, CA) using p-flurophenylalauine as an internal standard (6, 8) ; hydrolyses were carded out in 6 N Ha at 110"C for 18 h in tubes sealed
RESULTS

CNBr Cleavage of Embryonic N-CAM
CNBr fragments were generated from reduced and alkylated embryonic N-CAM and were fractionated on Sephacryl $300 (Fig. 2, upper panel) . Aliquots of fractions were removed for sialic acid analysis by the thiobarbituric acid assay (22) both before and after acid hydrolysis. After hydrolysis, three regions of sialic acid-containing material were seen: high molecular weight material associated with undigested or partially di- weight material was not free sialic acid because acid hydrolysis was required to obtain reactivity in the assay (22) , which detects only free sialic acid. Treament of embryonic N-CAM with 70% formic acid in the absence of CNBr yielded a similar low molecular weight, sialic acid-containing fraction with no associated peptide (Fig.  2 , lower panel). (Only a small amount of protein-associated absorbance was detected in the effluent because most of the N-CAM became insoluble after acid treatment.) The low molecular weight sialic acid material appeared to be polymeric sialic acid that had been attached through an acid-labile linkage inasmuch as it was retained on an 18% SDS polyacrylamide gel as a polydisperse region staining blue with "Stains-all," a carbocyanine cationic dye that forms a blue complex with anionic material including sialoproteins (23, 24) , phosphoproteins (15) , and acidic calcium-binding proteins (25) .
The sialic acid-containing fractions of intermediate molecular weight (Fig. 2 , upper panel) were pooled and rerun on the same column. This fractionation yielded polydisperse material on PAGE in the range of Mr 42,000-60,000 that was free of other detectable peptides (Fig. 3A, lane 1) . Upon neuraminidase treatment, the broad zone was reduced to a single Mr 42,000 band ( with neuraminidase (Fig. 3A, lane 3) , which suggested that the carbohydrate was N-linked and the sialic acid is attached to N-linked oligosaccharides. In both neuraminidase-and Endo F-treated material, components near Mr 66,000-68,000 are observed. Because these components are not present in untreated material and can be recognized by a monoclonal antibody specific for the peptide region of the fragment (see Figure 5 ), they are assumed to be aggregates of the deglycosylated peptide.
When CNBr fragments were prepared from affinity-purified adult N-CAM and separated on a Sephacryl $300 column, a sialic acid-containing component eluted at a slightly lower molecular weight than the embryonic sialopeptide, and no !ow molecular weight sialic acid-containing material was detected. The acid-labile sialic acid material thus appears to be a distinctive feature of the embryonic form of the molecule. After separation on SDS PAGE, the sialic acid-rich fraction from adult N-CAM contained a Mr 45,000 peptide ( Fig. 3 B , lane I) rather than the polydisperse material found in the embryonic N-CAM CNBr digest. This behavior on gels (polydisperse vs. banded) is comparable with that seen when E and A forms of the whole molecule are compared. In the same manner as the embryonic peptide, however, the adult Mr 45,000 peptide was reduced to a component of Mr 42,000 by neuraminidase treatment and to an Mr 35,000 component by Endo F treatment (Fig. 3B, lanes 2 and 3) . The adult N-CAM molecule thus has a sialic acid-containing region similar or identical to that in embryonic N-CAM.
The region represented by the embryonic and adult CNBr peptldes was identified as a major sialic acid-containing glycopeptide of N-CAM (1 l) by several criteria. The material isolated from embryonic N-CAM stained blue with "Stainsall" (Fig. 4A) , comparable with intact embryonic N-CAM. Moreover, the sialopeptide reacted on immunoblots with monoclonal antibody 15G8 (Fig. 4B) , the reactivity of which requires the presence of the high concentration of sialic acid associated only with the embryonic form of N-CAM (9, 10). A similar peptide was generated from Fr2, the fragment released from membranes by V-8 protease and known to contain >80% of the N-CAM sialic acid (Hemperly, J. J., and B. A. Cunningham, unpublished observation; also see below). The CNBr sialopeptide isolated from adult N-CAM contained less sialic acid, but upon neuraminidase or Endo F treatment was reduced to components of similar molecular weight as the embryonic peptide. These results suggest that the Mr 42,000 CNBr peptide is located in the central region of both the embryonic and adult molecule, representing most or possibly all of the difference between Frl and Fr2 (11).
Characterization of the CNBr Fragment
To determine whether the embryonic CNBr sialopeptide contained the majority of the sialic acid in N-CAM, the amino acid and sialic acid contents (Table I ) of the CNBr sialopeptide were determined. As a control, N-CAM was also treated under CNBr conditions (mock CNBr), and separated from the acidreleased sialic acid-containing material by gel fdtration on Sephadex G-50; analyses of this material were used to evaluate the loss of sialic acid caused by the acid treatment alone (Fig.  2, lower panel) . Mock treated N-CAM contained an average of 70% of the sialic acid present in the untreated molecule, indicating that as much as 30% of N-CAM sialic acid was spontaneously released under the acidic CNBr conditions. Because this material is polymeric sialic acid, is derived only from the embryonic form of the molecule, and accounts for up to 30% of the N-CAM sialic acid, we assume thal t is released from the major sialic acid containing region o~ the molecule. In support of this notion, treatment of the put aed embryonic CNBr sialopeptide with formic acid released ~raore low molecular weight material, indicating that this material can be generated from the CNBr sialopeptide.
The ratio of sialic acid to amino acid in the CNBr sialopeptide accounted for >90% of the sialic acid remaining in mock CNBr-treated N-CAM. We conclude that the CNBr sialopeptide represents a region that contains the major sites of :~alic acid attachment in the N-CAM molecule. Moreoer, the observation that the conditions used for CNBr treatment did not destroy the antigenic determinant recognized by the 15G8 antibody (Fig. 4B) suggest that at least part of the sialic acid moiety characteristic of embryonic N-CAM is retained in this fragment.
Location of the CNBr Sialopeptide within the Polypeptide Chain of N-CAM
The foregoing results suggested that the CNBr sialopeptide contained the majority of the N-CAM sialic acid and, therefore, that at least a portion of it was contained within Fr2 (Mr 108,000, see Fig. 1 ). It was important to demonstrate directly, however, whether the CNBr sialopeptide could account for the majority of the difference between Frl and Fr2. To show that the overlap between Frl and the CNBr sialopeptide was minimal and that the sialopeptide was almost completely included within Fr2, analysis of CNBr fragments with a monoclonal antibody specific for a peptide determinant of the sialic acid-rich region as well as peptide mapping procedures were used.
A number of monoclonal antibodies have been generated against various forms of N-CAM. An N-CAM monoclonal antibody, anti-(N-CAM) No. 2, was previously prepared and identified (6, 26) that reacted with both Mr 140,000 and Mr 170,000 polypeptide chains of N-CAM (26 and Fig. 5 ). This antibody reacts with Fr2 (Fig. 5 B) , but not with Frl (compare Sialic acid to amino acid ratios were calculated for N-CAM treated with formic acid to account for destruction of sialic acid by the acid treatment, for N-CAM treated with formic acid and then separated from released sialic acid material by chromatography on Sephadex G-50 to account for release of polymers of sialic acid by the acid treatment, and for the purified CNBr sialopeptide. * Molecular weights estimated from SDS PAGE. * Percentage of sialic acid retained was calculated relative to molecular weight, i.e., if the CNBr sialopeptide contained all of the N-CAM sialic acid, it, theoretically, would have 3.3 times (140,000/42,000) the amount of sialic acid per I00 tool of amino acid. As shown above, this expectation was met. i From reference 6. , and Frl (lane 4) were prepared as described (11). These fragments were purified by cutting them from polyacrylamide gels, and were rerun on a 7.5% gel similar to the Cleveland procedure (18) . A nitrocellulose blot (17) with Fig. 5 A, which is stained with rabbit polyclonal anti-N-CAM). The recognition site of this antibody therefore appears to be within the sialic acid-containing region of the molecule (i.e., the region represented by the difference between Fr2 and Frl).
Having shown that anti-(N-CAM) No. 2 reacted with the middle region of N-CAM polypeptide, we next tested its reactivity with the CNBr fragment. Immunoblot analysis of the CNBr sialopeptide demonstrated that anti-(N-CAM) No. 2 reacted with the sialic acid-containing CNBr fragment from embryonic and adult N-CAM both before and after treatment with neuraminidase or with Endo F (Fig. 6 ). These observations suggest that the antibody recognized a peptide determinant because Endo F removes both high mannose and complex types of N-linked sugars (20) ; O-linked sugars have not been demonstrated in N-CAM. Furthermore, for an equivalent amount of protein, Endo F-treated material reacted much more strongly with anti-(N-CAM) No. 2 (see Fig. 8 ), supporting the notion that the antigenic determinant is a peptide.
These results indicated that Fr2 and the CNBr sialopeptide had a common peptide antigenic determinant. To determine whether the CNBr sialopeptide was included within Fr2, CNBr fragments were generated from Fr2 after digestion with neuraminidase and analyzed by the immunoblot method using anti-(N-CAM) No. 2. This treatment of Fr2 yielded an anti-(N-CAM) No. 2 reactive component (Fig. 7A, lane 1) that co-migrated with the purified neuraminidase-treated CNBr sialopeptide (Fig. 7A, lane 2) . Several higher molecular weight components were observed, and because this digest was not subjected to fractionation before the immunoblot analysis, were presumed to be partial CNBr products of Fr2. Similar partial cleavages have been seen in unfractionated CNBr digests of the intact molecule. These results strongly suggested that the CNBr sialopeptide is contained within Fr2.
Limited proteolytic mapping using S. aureus V-8 protease was also used to determine the relationship between Fr2 and the CNBr sialopeptide, and to corroborate the results obtained with monoclonal antibodies. The proteolytic map of neuraminidase-treated Fr2 and the CNBr sialopeptide was analyzed both by silver staining and by the immunoblot technique using anti-(N-CAM) No. 2 as a probe for peptides corresponding to the sialic acid-containing region. A prominent doublet of M, 16,000 was generated from both Fr2 and the Mr 42,000 CNBr peptide (Fig. 7B, lanes I and 2) and all fragments generated from the CNBr peptide were also found in the digest of Fr2. When the peptide maps were transferred to nitrocellulose and reacted with anti-(N-CAM) No. 2, both Fr2 and the CNBr sialopeptide yielded a major reactive band of Mr 16,000 (Fig. 7 C) , which may correspond to one or both of the components of the doublet. Furthermore, in a separate experiment, cleavage of Fr2 resulted in several anti-(N-CAM) No. 2 reactive partial cleavage products, one of which migrated with the uncleaved CNBr fragment, suggesting that the V-8 cleavage of Fr2 generates a peptide similar in size to the CNBr sialopeptide. It is important to note in this V-8 peptide analysis that Fr2 was originally generated by V-8 protease cleavage of N-CAM from membranes, and that it contained the amino terminus of intact N-CAM. Thus, fragments produced from Fr2 that do not appear in Frl should be derived from the carboxyl terminal region of Fr2 (see Fig. 1 ). The combined results indicate that the sialic acid-rich CNBr fragment is contained almost solely within Fr2, and that it is closely aligned with the difference peptide between Frl and Fr2. A more precise alignment must await extensive amino acid sequence determination.
Number of Oligosaccharide Attachment Sites in the CNBr Sialopeptide
After treatment with neuraminidase to reduce its polydispersity, the CNBr sialopeptide was separated from the enzyme by gel fdtraton. Equal aliquots of this fragment were then exposed to various concentrations of Endo F, and the products were assessed by the immunoblot technique with anti-(N-CAM) No. 2 in order to differentiate the product from components of the enzyme, all of which have similar molecular weights. As previously found for other glycoproteins containing N-glycosidic linkages (20, 21) , a spectrum of intermediatesized species resulted from the sequential removal of the sugar chains; the highest and lowest are assumed to be, respectively, the undigested molecule and the completely digested peptide free of N-linked sugars. The total number of species generated should therefore be one greater than the number of N-linked carbohydrate attachment sites. The CNBr sialopeptide yielded a total of four components (Fig. 8A) , suggesting that within this region there are three asparagine-linked sugar chains. Sialic acid may be a constituent of one, two, or all three of the chains.
A similar analysis was performed on adult material to determine whether the adult molecule contained the same number of attachment sites, i.e., whether E-A conversion left these sites intact. After treatment with neuraminidase and Endo F, as described above for the purified embryonic ma- terial, analysis by immunoblots also gave four components (Fig. 8B ) of sizes similar to those obtained from embryonic material, indicating that adult N-CAM also contains three carbohydrate attachment sites within the comparable fragment.
DISCUSSION
Structural analysis of N-CAM provides a unique opportunity to define mechanisms of cell surface modulation (1, 2) and to study the function of'covalently linked carbohydrate in a glycoprotein that itself has a well-defined function at the cell surface. The unusual sialic acid of N-CAM has a marked effect on N-CAM binding (12) and appears to be the feature of the molecule that is altered in E-A conversion (l, 2, 9, 10). The present results are summarized and incorporated into the proposed model for N-CAM, as shown in Fig. 9 . Previous studies (l 1) localized the sialic acid of embryonic N-CAM to a middle region of the linear sequence represented by the difference between Frl, which is spontaneously released by 2. Based on its molecular weight, sialic acid content, and mono. clonal antibody reactivity, the sialopeptide appears to account for much of the difference peptide between Fr2 and Frl in embryonic and adult N-CAM, but its precise alignment remains to be determined.
incubation of solutions of N-CAM, and Fr2, which is released from membranes with V-8 protease. The major CNBr sialopeptide identified in the present studies corresponded to a large segment of this middle region. The embryonic sialopeptide appeared as a polydisperse material ranging from Mr 42,000 to Mr 60,000 on SDS PAGE and was converted to a component of Mr 42,000 upon treatment with neuraminidase. Quantitative comparisons of sialic acid and amino acid content of this fragment with those of mock CNBr-treated N-CAM confirmed that it contained the majority of N-CAM sialic acid. CNBr fragmentation of Fr2 yielded a component that co-migrated with the purified N-CAM CNBr sialopeptide and also reacted with anti-(N-CAM) No. 2. In addition, the CNBr sialopeptide yielded a V-8 protease peptide map which overlapped the map of Fr2. These results indicated that the CNBr sialopeptide is almost completely contained within Fr2, and that it has little or no overlap with Frl.
The CNBr sialopeptide reacted with two monoclonal antibodies specific for determinants on distinctive regions of N-CAM. Monoclonal antibody 15G8 characteristically reacts only with embryonic N-CAM, and the reactive antigenic determinant appears to depend upon the presence of polymeric sialic acid. In contrast, anti-(N-CAM) No. 2 antibodies recognized a peptide determinant in the region where the sugar moieties are attached. This antibody also detects both the Mr 170,000 and 140,000 polypeptides of N-CAM (26), suggesting that they are similar in this portion of their structure. Earlier studies (11) indicated that the two polypeptides had the same amino terminal sequence and gave similar peptide maps, but revealed no details about their possible similarities in the carbohydrate attachment region.
Characterization of the CNBr sialopeptide with Endo F indicated that there are three potential attachment sites for sialic acid in N-CAM. Attempts to perform such analyses on intact N-CAM or Fr2 were inconclusive because the decrease in molecular weight due to removal of the carbohydrate by Endo F from such a large molecule was too small to resolve 1854 THE JOURNAL OF CELL BIOLOGY -VOLUME 99, 1984 bands of intermediate molecular weight; furthermore, there was ambiguity due to the existence of Mr 140,000 and 170,000 polypeptides of N-CAM (8, 11) . It is important to note that, to detect the sequential digestion products of the CNBr sialopeptide, it was first necessary to remove the sialic acid from the fragment; this analysis, therefore, indicates the maximum number of chains that could terminate in sialic acid. Whether one, two, or all three sites contain sialic acid will require isolation of smaller glycopeptides and extensive carbohydrate analysis.
The CNBr sialopeptide is to date the smallest fragment isolated that contains the bulk of the sialic acid. Preliminary studies of proteolytic digests (e.g., trypsin) yield material that stains with "Stains-all" and appears on both gel fdtrafion and SDS PAGE as a broad zone of Mr >20,000. This material separates into over overlapping zones on PAGE but no peptides are detectable with Coomassie Blue when the sialic acid is removed. Endoglycosidase F treatment of intact N-CAM releases similar high molecular weight material that stains blue with "Stains-all" and migrates on SDS PAGE in two similar zones. These results suggest that major sialic acid components may be attached to at least two of the three sites.
In view of the physiological and functional significance of E-A conversion, it was particularly important to determine whether a comparable CNBr fragment could be obtained from the A form of N-CAM and whether it had the same number of N-linked oligosaccharides. A CNBr sialopeptide from adult N-CAM was identified and shown to be analogous to the embryonic sialopeptide in size, and in its reactivity with anti-(N-CAM) No. 2. Most significantly, partial cleavage with Endo F followed by analysis on immunoblots indicated that the adult sialopeptide also contained three attachment sites for N-linked carbohydrate. This finding suggests that the adult and embryonic peptides differ only in their content and arrangement of terminal sialic acids, not in the gross location or number of N-linked oligosaccharide chains on the polypeptide. Although the precise mechanism of E-A conversion is unknown, a reasonable hypothesis is that it involves alterations in enzymes acting on N-CAM, which control the addition or removal ofsialic acid (1, 2, 9, 10). The comparison of E and A forms in terms of their CNBr sialopeptides and carbohydrate attachment sites carried out here confirms that alterations in the sialic acid rather than in the sites themselves are involved in E-A conversion, and clearly focuses attention upon sialic acid-specific enzymes. Nonetheless, it should be pointed out that the presence of small amounts of sialic acid in short attachment sites other than the sites susceptible to the enzymes used in the present study cannot be excluded. Exploration of this possibility will have to await detailed studies of amino acid sequences.
It has been proposed (1, 2) that alterations in the sialic acidrich domain modulate the binding of N-CAM either by a charge perturbation or by steric effects. The suggestion that polysialic acid occurs at possibly two or three sites near the binding domain increases the opportunities for different amounts of sialic acid to affect the binding efficacy, especially if all of the sialic acid-containing intermediates can differentially affect N-CAM binding. This model would provide a basis for diversity in binding behavior and could explain such observations as the differences in the conversion rates among different brain regions (10) . Inasmuch as the presence or absence of a particular carbohydrate moiety can also affect protein structure, this charge perturbation model might also
